-
Mashup Score: 0FDA Approves New Indication for Chronic Disease Treatment - 3 year(s) ago
FDA approves chronic disease treatment Xywav, to treat cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy.
Source: PharmaNewsIntelligenceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
An expert committee has developed 70 reform recommendations for the pharmaceutical supply chain to increase transparency, access, and affordability.
Source: PharmaNewsIntelligenceCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Pharmaceutical #SupplyChain Needs Reform for Transparency, Access - An expert committee has developed 70 reform recommendations for the pharmaceutical supply chain to increase transparency, access, and affordability https://t.co/OetadkMRIZ
-
-
Mashup Score: 0
Nearly 50% of global healthcare companies will implement artificial intelligence strategies and by 2025 and some experts believe it is crucial for how businesses operate down the line.
Source: PharmaNewsIntelligenceCategories: Healthcare Professionals, Latest HeadlinesTweet-
#AI in the #Pharma Industry: Current Uses, Best Cases, Digital Future https://t.co/Lic1HE71IY
-
-
Mashup Score: 0Medical AI Device Evaluation Process Could Mask Vulnerabilities - 3 year(s) ago
A majority of data test sets from FDA-approved medical AI devices were collected and evaluated before device deployment rather than concurrently, which can mask vulnerabilities.
Source: PharmaNewsIntelligenceCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Medical #AI Device Evaluation Process Could Mask Vulnerabilities - A majority of data test sets from #FDA-approved medical AI devices were collected and evaluated before device deployment rather than concurrently, which can mask vulnerabilities https://t.co/TsuYPhPZg7
-
-
Mashup Score: 0US Prescription Drug Prices 256% Higher Than Other Countries - 3 year(s) ago
A RAND Corporation report found that US prescription drug prices are significantly higher than other countries, including 218% higher than prices in Canada, 170% higher than prices in Mexico, and 779% higher than prices in Turkey.
Source: PharmaNewsIntelligenceCategories: Healthcare Professionals, Latest HeadlinesTweet-
#US #PrescriptionDrug Prices 256% Higher Than Other Countries - Specifically, US prescription drug prices were 218% of prices in Canada, 170% of prices in Mexico, 779% of prices in Turkey, and 209%of prices in Japan. | #pharma https://t.co/CM8WLObyw1
-
-
Mashup Score: 0Cybersecurity Best Practices for the Pharma Sector Amid COVID-19 - 4 year(s) ago
The pharma sector has become a prime target for cyberattacks throughout the COVID-19 pandemic. Companies must understand both the current threat landscape and best practices to secure key data.
Source: PharmaNewsIntelligenceCategories: Future of Medicine, Latest HeadlinesTweet-
#Cybersecurity Best Practices for the #Pharma Sector Amid COVID-19 https://t.co/lNsBydvqbB https://t.co/ppKEnEW8ft
-
-
Mashup Score: 1How Is Real-World Evidence Impacting Drug Discovery, Development - 4 year(s) ago
The pharmaceutical industry is turning to real-world evidence to improve drug discovery and development, a trend that should continue into the coming years.
Source: PharmaNewsIntelligenceCategories: Future of Medicine, Latest HeadlinesTweet-
“How Is Real-World Evidence Impacting Drug Discovery, Development - The pharmaceutical industry is turning to real-world evidence to improve #drugdiscovery and development” https://t.co/vf0oyf3how #drugdevelopment https://t.co/FI5I1eNN1T
-
-
Mashup Score: 1Early Data Indicates Remdesivir is a Promising COVID-19 Drug - 4 year(s) ago
A new study uncovered that potential COVID-19 drug, remdesivir, improved in 68% of patients. But, there may be challenges with limited study data.
Source: PharmaNewsIntelligenceCategories: Healthcare Professionals, Latest HeadlinesTweet-
Early Data Indicates #Remdesivir is a Promising #COVID19 Drug https://t.co/xqe9KbW65A
-
-
Mashup Score: 04 of the Most Promising COVID-19 Vaccines In Development - 4 year(s) ago
With the US reporting the most coronavirus cases of any other country, experts voice what they believe to be the four most promising COVID-19 vaccines currently in development.
Source: PharmaNewsIntelligenceCategories: General Medicine Journals and SocietiesTweet-
Pharmaceutical companies are working to develop #COVID19 vaccines as the virus worsens each day. The following are the most promising vaccines according to experts. https://t.co/kGID3SegtK
-
-
Mashup Score: 0Phase 1 Clinical Trial for Coronavirus Vaccine Begins in Seattle - 4 year(s) ago
A phase 1 clinical trial testing an investigational coronavirus vaccine has begun in Seattle, testing the safety of dosages and the immune response in human study participants.
Source: PharmaNewsIntelligenceCategories: Healthcare ProfessionalsTweet-
Phase 1 #ClinicalTrial for #Coronavirus #Vaccine Begins in #Seattle https://t.co/xEeCIOWuwd
-
#FDA Approves New Indication for #ChronicDisease Treatment, Xywav, to treat #cataplexy or excessive daytime sleepiness in patients seven years of age and older with #narcolepsy, idiopathic #hypersomnia (IH) | @JazzPharma $JAZZ https://t.co/E0pBgMoIWl